COLL - Collegium Pharmaceutical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

COLL is currently covered by 5 analysts with an average price target of $37.17. This is a potential upside of $7.27 (24.31%) from yesterday's end of day stock price of $29.9.

Collegium Pharmaceutical's activity chart (see below) currently has 85 price targets and 90 ratings on display. The stock rating distribution of COLL is 62.96% BUY and 37.04% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.47% with an average time for these price targets to be met of 898.78 days.

Highest price target for COLL is $50, Lowest price target is $37, average price target is $42.6.

Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 09-May-2025. First documented stock forecast 01-Jun-2015.

Currently out of the existing stock ratings of COLL, 17 are a BUY (62.96%), 10 are a HOLD (37.04%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$37

$7.17 (24.04%)

$36

1 months 17 days ago
(09-May-2025)

15/18 (83.33%)

$8.11 (28.07%)

900

Buy

$46

$16.17 (54.21%)

$46

2 months 17 days ago
(09-Apr-2025)

23/25 (92%)

$19.63 (74.44%)

553

Buy

$50

$20.17 (67.62%)

$50

3 months 2 days ago
(24-Mar-2025)

5/9 (55.56%)

$19.44 (63.61%)

700

Buy

$40

$10.17 (34.09%)

$44

7 months 15 days ago
(11-Nov-2024)

1/3 (33.33%)

$7.82 (24.30%)

316

Buy

$40

$10.17 (34.09%)

$37

1 years 4 months ago
(26-Feb-2024)

7/7 (100%)

$3.44 (9.41%)

175

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is COLL (Collegium Pharmaceutical) average time for price targets to be met?

On average it took 898.78 days on average for the stock forecasts to be realized with a an average price target met ratio 65.47

Which analyst has the current highest performing score on COLL (Collegium Pharmaceutical) with a proven track record?

DAVID STEINBERG

Which analyst has the current lower performing score on COLL (Collegium Pharmaceutical) with a proven track record?

GLEN SANTANGELO

Which analyst has the most public recommendations on COLL (Collegium Pharmaceutical)?

David Steinberg has 2 price targets and 2 ratings on COLL

Which analyst is the currently most bullish on COLL (Collegium Pharmaceutical)?

Oren Livnat with highest potential upside - $20.17

Which analyst is the currently most reserved on COLL (Collegium Pharmaceutical)?

Hamed Khorsand with lowest potential downside - -$29.13

Collegium Pharmaceutical in the News

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

– Generated Q1’25 Quarterly Net Revenue of $177.8 Million,Up 23% Year-over-Year – – Grew Jornay PM® Prescriptions by 24% Year-over-Year and Reported Quarterly Net Revenue of $28.5 Million; Jornay PM Prescribers Reached an All-Time-High – – Completed Jornay PM Field Force Expansion – – Generated Net Revenue of $149.2 Million from the Pain Portfolio, Up...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?